B.Riley on Ovid Therapeutics Inc (OVID): 'one of our top picks from last week's B. Riley MMV Summit'

July 21, 2026 5:16 AM

B.Riley analyst Madison El-Saadi reiterated a Buy rating and $5.00 price target on Ovid Therapeutics Inc (NASDAQ: OVID).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found